The advisory panel wasn’t convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
Source: US Top News and Analysis
Related Posts
BMW says it has no intention of dropping sedans, even as some rivals cut back
The BMW 7-Series gets one of the most extensive updates any model has received in…
Apple delivers a nearly perfect quarter, with a CEO change and an AI update ahead
In fact, it was the best March quarter in company history, and Apple stock jumped…
Anthropic unveils plans for major UK expansion after OpenAI announces first permanent London office
The move follows a U.K. campaign to court the U.S. company following its fallout with…